Most Clicked DiabetesPro SmartBrief Stories

1. Study suggests fructose may promote obesity, diabetes

DiabetesPro SmartBrief | Oct 16, 2014

Harvard Medical School researchers say fructose may lead to increases in a hormone that regulates fat accumulation and could promote diabetes and obesity. The study in Molecular Metabolism says fructose stimulated the biggest increases in the hormone among obese people, but the response varied, even among those who were not overweight. New York Times (tiered subscription model), The (10/13)

2. Dexcom gains FDA approval for wireless glucose monitoring device

DiabetesPro SmartBrief | Oct 21, 2014

The FDA gave pre-market approval for the Dexcom Share device, which wirelessly transmits data from the company's G4 Platinum continuous glucose monitor to designated smartphones as part of a remote glucose monitoring system. (Boston) (10/20)

3. Enterovirus infection linked to type 1 diabetes risk in children

DiabetesPro SmartBrief | Oct 20, 2014

Children infected with enterovirus were about 50% more likely to develop type 1 diabetes compared with uninfected children, Taiwanese researchers wrote in the journal Diabetologia. Older age at infection diagnosis was associated with a greater likelihood of diabetes, the researchers said. Science World Report (10/19)

4. ADA position statement addresses diabetes in child care setting

DiabetesPro SmartBrief | Oct 15, 2014

A position statement in Diabetes Care stresses that pediatric diabetes patients need a proactive disease care plan that involves clinicians, parents/guardians and child care staff. Researchers also highlighted hurdles in pediatric diabetes care, including language barriers, health literacy and ethnic and cultural practices. (10/14)

5. Men with diabetes, low testosterone show higher heart risks

DiabetesPro SmartBrief | Oct 17, 2014

Data on 115 male type 2 diabetes patients showed those with low testosterone levels were six times as likely to suffer increased carotid thickness and endothelium dysfunction than those who had normal testosterone. The results were published in The Journal of Clinical Endocrinology & Metabolism. (10/16)

6. Empagliflozin improves BP, A1C in patients with diabetes

DiabetesPro SmartBrief | Oct 15, 2014

Data on patients with type 2 diabetes and hypertension revealed those on empagliflozin treatment attained significant improvements in blood pressure levels, A1C and body weight at 12 weeks compared with those in the placebo cohort. The findings appear in Diabetes Care. Medscape (free registration) (10/14)

7. Toolkit to help docs discuss obesity care with patients

DiabetesPro SmartBrief | Oct 15, 2014

The Accreditation Association for Ambulatory Health Care has introduced a new toolkit called "Disease Management: Obesity in Adults" to encourage doctors to discuss weight management options with their obese patients. (10/14)

8. Trial underway for Medtronic's Predictive Low Glucose Management tech

DiabetesPro SmartBrief | Oct 21, 2014

Medtronic has begun patient enrollment in a clinical study of its Predictive Low Glucose Management system, which combines a continuous glucose monitor and an advanced insulin pump into a single unit. The study, which will involve 84 participants from as many as eight U.S. clinical sites, will test whether the device is safe and effective in helping control hypoglycemia and rebound hyperglycemia. Healio (free registration) (10/18)

9. Mediterranean diet may help reduce obesity, diabetes risks

DiabetesPro SmartBrief | Oct 15, 2014

Participants who followed a Mediterranean diet supplemented with olive oil attained significant improvements in obesity and blood glucose levels at nearly five years, while those who followed a Mediterranean diet supplemented with nuts exhibited reductions in obesity, according to a study in CMAJ. However, researchers did not observe a difference in metabolic syndrome incidence between the Mediterranean diet groups and the controls who followed a low-fat diet. (10/14)

10. Drug thwarts gene variant that inhibits insulin secretion

DiabetesPro SmartBrief | Oct 16, 2014

A small study in Science Translational Medicine found the medication yohimbine helped promote insulin secretion in diabetes patients who carry a gene variant that inhibits insulin secretion. The drug could be effective for 40% of patients with type 2 diabetes, researchers said. Business Standard (India) (10/15)

Sign up for DiabetesPro SmartBrief

Designed specifically for health care professionals, DiabetesPro SmartBrief is a FREE, daily e-mail newsletter. It provides the latest news, trends, and technology updates that matter most to health care professionals. Learn more